INS and hydrops fetalis: Table 2 summarizes HF-relevant effects and clinical recommendations across glucose-lowering drug classes, highlighting benefits with SGLT2 inhibitors/GLP-1 RAs, metformin’s favorable profile in stable HF, and the need for caution or avoidance with sulfonylureas, insulin, and TZDs.